New study aims to boost HIV prevention in meth-using men

NCT ID NCT06637436

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two approaches to help men who have sex with men and use methamphetamine start or restart HIV prevention (PrEP) or treatment (ART). 400 participants will receive either contingency management (rewards for filling prescriptions) alone or combined with motivational interviewing, all via telehealth. The goal is to see which method works better at getting people to fill their HIV medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Florida International University

    RECRUITING

    Miami, Florida, 33199, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.